$20.5 Million is the total value of Brevan Howard Capital Management LP's 2 reported holdings in Q1 2017. The portfolio turnover from Q4 2016 to Q1 2017 was 100.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| CME | CME GROUP INC | $12,183,000 | +3.0% | 102,553 | 0.0% | 59.41% | +70.0% | |
| ASHR | New | DBX ETF TRcall | $8,323,000 | – | 331,200 | +100.0% | 40.59% | – |
| IBB | Exit | ISHARES TRnasdq biotec etf | $0 | – | -83,000 | -100.0% | -65.06% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2017-05-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| CME GROUP INC | 30 | Q3 2023 | 65.1% |
| VALE SA-SP ADR | 10 | Q3 2023 | 8.1% |
| ISHARES TR | 9 | Q3 2023 | 6.9% |
| ISHARES TR | 8 | Q3 2023 | 49.4% |
| VANECK VECTORS ETF TR | 8 | Q3 2023 | 23.2% |
| Global X Uranium ETF | 8 | Q2 2023 | 6.6% |
| ISHARES MSCI SOUTH AFRICA IN | 8 | Q3 2023 | 0.5% |
| SPDR TRUST SERIES 1 | 7 | Q1 2023 | 91.4% |
| ISHARES TR | 7 | Q3 2023 | 11.3% |
| ISHARES TR | 7 | Q2 2023 | 24.2% |
View Brevan Howard Capital Management LP's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-14 |
| 13F-HR | 2021-11-12 |
View Brevan Howard Capital Management LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.